High incidence of graft failure in children receiving CD34+ augmented elutriated allografts for nonmalignant diseases.
Bone Marrow Transplant., Jun;31(12):1073-80 (2003)
CD34+ stem cell augmentation of elutriated allogeneic bone marrow grafts: results of a phase II clinical trial of engraftment and graft-versus-host disease prophylaxis in high-risk hematologic malignancies.
Bone Marrow Transplant., Nov;22(10):947-55 (1998)
Philadelphia chromosome-negative engraftment after autologous transplantation with granulocyte-macrophage colony-stimulating factor for chronic myeloid leukemia.
Biol. Blood Marrow Transplant., 5(6):394-9 (1999)
Acute bleeding after allogeneic bone marrow transplantation: association with graft versus host disease and effect on survival.
Transplantation., Mar;67(5):681-9 (1999)
Engineering hematopoietic grafts using elutriation and positive cell selection to reduce GVHD.
Cancer Treat. Res., 101:311-30 (1999)
Semin. Oncol., Apr;27(2 Suppl 5):15-21 (2000)
Long-term results of blood and marrow transplantation for Hodgkin's lymphoma.
J. Clin. Oncol., Dec;19(23):4314-21 (2001)
Low incidence of neutropenic events in patients with lymphoma receiving first-cycle pegfilgrastim with chemotherapy: results from a prospective community-based study.
Clin Lymphoma Myeloma., May;7(6):413-20 (2007)
Lymphocyte depletion in bone marrow transplantation: will modulation of graft-versus-host disease prove to be superior to prevention?
Semin. Oncol., Oct;20(5 Suppl 6):28-33 (1993)
Administration of human recombinant granulocyte colony-stimulating factor (filgrastim) accelerates granulocyte recovery following high-dose chemotherapy and autologous marrow transplantation with 4-hydroperoxycyclophosphamide-purged marrow in women with m
Cancer Res., Nov;53(22):5424-8 (1993)
Bone marrow micrometastases in chemotherapy-responsive advanced breast cancer: effect of ex vivo purging with 4-hydroperoxycyclophosphamide.
Cancer Res., May;54(9):2366-71 (1994)
Large-volume leukapheresis using regional citrate anticoagulation to collect peripheral blood progenitor cells.
J Hematother., Feb;4(1):11-9 (1995)
Absence of breast cancer cells in a single-day peripheral blood progenitor cell collection after priming with cyclophosphamide and granulocyte-macrophage colony-stimulating factor.
Blood., Feb;85(4):1138-43 (1995)
Predictive factors for peripheral-blood progenitor-cell collections using a single large-volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony-stimulating factor mobilization.
J. Clin. Oncol., Mar;13(3):705-14 (1995)
Similar breast cancer cell contamination of single-day peripheral-blood progenitor-cell collections obtained after priming with hematopoietic growth factor alone or after cyclophosphamide followed by growth factor.
J. Clin. Oncol., Sep;14(9):2569-75 (1996)
CD34 augmentation improves allogeneic T cell-depleted bone marrow engraftment.
J Hematother., Apr;7(2):151-7 (1998)
Chemotherapy does not nullify the ability of donor lymphocyte infusions to mediate graft-versus-host reactions.
Bone Marrow Transplant., Aug;22(3):303-5 (1998)
Separation of rat bone marrow cells by counterflow centrifugal elutriation: a model for studying the effects of lymphocyte depletion.
Exp. Hematol., Mar;16(3):206-12 (1988)
Cyclosporine A enhances the natural suppressor monocyte precursor population in the rat.
Transplant. Proc., Jun;20(3 Suppl 3):1057-67 (1988)
Lymphocyte depletion of donor bone marrow by counterflow centrifugal elutriation: results of a phase I clinical trial.
Blood., Oct;72(4):1168-76 (1988)